Holz, F G
Tadayoni, R
Beatty, S
Berger, A R
Cereda, M G
Hykin, P
Staurenghi, G
Wittrup-Jensen, K
Nilsson, J
Kim, K
Sivaprasad, S
Article History
Received: 13 January 2016
Accepted: 23 March 2016
First Online: 20 May 2016
Competing interests
: Frank G Holz is a consultant to Acucela, Genentech, Novartis, Bayer Pharmaceuticals, Alcon, OPTOS, Heidelberg Engineering, Carl Zeiss Meditec, Allergan, and Pfizer; and has received grants from OPTOS, Heidelberg Engineering, Carl Zeiss Meditec, Alcon, Genentech, Bayer Pharmaceuticals, and Novartis. Ramin Tadayoni is a board member of Alcon, Novartis, Allergan, Bausch & Lomb, Pfizer, Alimera, Bayer Pharmaceuticals, and FCI-Zeiss; and a consultant for Allergan, DORC, Alcon, Novartis, Takeda, Bausch & Lomb, and FCI-Zeiss. He has received payment for lectures from Alcon, Bausch & Lomb, Novartis, Allergan, Pfizer, Takeda, Bayer Pharmaceuticals, and Alimera; and has received payment for development of educational presentations from Bausch & Lomb, Novartis, Zeiss, Sony, Alcon, and Allergan. He has also received support for meeting expenses (travel and accommodation) from Alcon, Novartis, Allergan, Bausch & Lomb, Pfizer, Bayer Pharmaceuticals, DORC, Takeda, Servier, and Alimera. Stephen Beatty is a consultant and board member for Bayer Pharmaceuticals, and has received support for travel to meetings and fees for participation in review activities from Bayer Pharmaceuticals. Alan R Berger has received honoraria from Bayer Pharmaceuticals, Novartis, Alcon, and Allergan; institutional research funding support from Bayer Pharmaceuticals, Novartis, and Alcon; and fellowship support funding from Alcon, Bayer Pharmaceuticals, Novartis, and Woodgreen Pharmacy. He has received travel fees and speaker fees and participated in advisory boards for Bayer Pharmaceuticals and Novartis. Matteo G Cereda is a consultant to Bayer Pharmaceuticals and has received support for travel to meetings from Bayer Pharmaceuticals and Alcon. Philip Hykin has received grants from Bayer Pharmaceuticals, Allergan, and Novartis; and acts as a consultant to Bayer Pharmaceuticals, Allergan, and Novartis. He has also received support for travel to meetings, participation in review activities, and provision of writing assistance, medicines, equipment, or administrative support from Bayer Pharmaceuticals. He has received payment for lectures from Allergan and Novartis. Giovanni Staurenghi acts as a consultant to Novartis, Bayer Pharmaceuticals, Allergan, Genentech, Roche, Heidelberg Engineering, and Alcon. He has also received support for travel to meetings from Bayer Pharmaceuticals, Centervue, Heidelberg Engineering, and Novartis. He has received payment for lectures from Zeiss, and is a patent holder in conjunction with Ocular Instruments, Inc. He has received payment for development of educational presentations for Roche. Sobha Sivaprasad has received research grants from Bayer Pharmaceuticals, Novartis, and Allergan that were paid to her institution. She has received travel fees and speaker fees, and has participated in advisory boards for Bayer Pharmaceuticals, Novartis, and Allergan, and has participated in an advisory board meeting for Roche. Kim Wittrup-Jensen is an employee of Bayer Pharmaceuticals. Jonas Nilsson and Kun Kim are employees/former employees of Mapi Group who were contracted by Bayer Pharmaceuticals to perform the analyses.